PROGRAM SCHEDULED for June 8-11, 2015 | Newark, New Jersey
Your First and
Last Stop for
Join Seton Hall Law School faculty and respected industry leaders for a comprehensive overview of state, federal, and international law governing prescription drugs and medical devices. This four-day program immerses attendees in the statutes, regulations and other guidance that comprise the body of law known as “fraud and abuse law.” Examine healthcare-related laws and regulations alongside other compliance, ethics and integrity officers, legal counsel, healthcare consultants, and regulatory and medical affairs professionals. Engage in group problem-solving activities and analyze the covered laws and regulations through case studies. Discover how to create a culture of compliance and leave with the skills necessary to develop, enhance and enforce your organization’s corporate compliance program.
- Data Privacy - HIPAA, HITECH, and others
- FDA approval and regulation of new drugs and devices
- Federal Anti-Kickback Statute
- Federal and State False Claims Acts
- Federal Sunshine Law
- Foreign Corrupt Practices Act (FCPA) - including worldwide anti-corruption and enforcement
- Government Investigations
- Healthcare fraud sentencing, penalties, damages, and other considerations
- OIG Compliance
- Prescription drug and device marketing and advertising
Cost & Registration
Individual registration: $2400.
Group discounts are available for companies sending multiple employees to the same program. Email us at firstname.lastname@example.org for details. Members of supporting organizations also may be eligible for discounts. Find our supporters here.
The U.S. Healthcare Compliance Certification Program is offered through the Seton Hall Law School Center for Health & Pharmaceutical Law & Policy, a leading center for research and scholarship. The Center educates lawyers and professionals in the healthcare and life sciences industries regarding the intricate and multifaceted set of laws that govern patients, healthcare providers, manufacturers, and suppliers. Center faculty and research fellows produce scholarship, white papers and recommendations for policy on the varied and complex issues posed by health and pharmaceutical law, health care access, human subject research, mental health issues, and non-profit governance. The Center fosters informed dialogue among policymakers, consumer advocates, the medical profession and industry in the search for solutions to the ethical, legal, and social questions presented in the health and pharmaceutical arena. Read more about the Center and faculty scholarship.